Autolus Therapeutics plc Files 8-K
Ticker: AUTL · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1730463
| Field | Detail |
|---|---|
| Company | Autolus Therapeutics PLC (AUTL) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
Related Tickers: AUTL
TL;DR
Autolus Therapeutics filed an 8-K on 3/20/25 covering financials and operations.
AI Summary
Autolus Therapeutics plc filed an 8-K on March 20, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in England and Wales and its principal executive offices are located in London.
Why It Matters
This 8-K filing provides an update on Autolus Therapeutics' financial condition and operations, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing providing operational and financial updates, not indicating any immediate material adverse events.
Key Players & Entities
- Autolus Therapeutics plc (company) — Registrant
- March 20, 2025 (date) — Date of earliest event reported
- England and Wales (jurisdiction) — State or other jurisdiction of incorporation or organization
- The Mediaworks 191 Wood Lane London W12 7FP United Kingdom (address) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Autolus Therapeutics plc's results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 20, 2025.
In which jurisdiction was Autolus Therapeutics plc incorporated?
Autolus Therapeutics plc was incorporated in England and Wales.
What is the address of Autolus Therapeutics plc's principal executive offices?
The address of Autolus Therapeutics plc's principal executive offices is The Mediaworks 191 Wood Lane London W12 7FP United Kingdom.
What is the SEC file number for Autolus Therapeutics plc?
The SEC file number for Autolus Therapeutics plc is 001-38547.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Autolus Therapeutics plc (AUTL).